Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Seekyo
company
About
SEEKYO is a privately-owned biotech company developing the next generation of chemotherapies.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- €650K
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Seekyo is a privately-owned biotech company that develops the next generation of chemotherapiesBy targeting the microenvironment of solid tumors while sparing healthy tissues, our aim is to provide treatments without adverse effects to cancer patients.Seekyo’s Smart Drugs transport potent anticancer agents in an innocuous manner toward safe tissues, provide efficient recognition of malignant specificities thanks to its targeting unit and allow the controlled release of the parent drug exclusively at the tumour site, based on its versatile enzyme-responsive self-immolative linker.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€650K
Seekyo has raised a total of
€650K
in funding over 2 rounds. Their latest funding was raised on
Jan 20, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 20, 2020 | Seed | €650K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Seekyo is funded by 1 investors.
French Tech Acceleration Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
